FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Tables)
|
3 Months Ended |
Mar. 31, 2017 |
Fair Value Disclosures [Abstract] |
|
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The following tables present the Company's financial instruments that are measured at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | March 31, 2017 | | Quoted Market Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total Fair Value Measurements | | (In thousands) | Assets: | | | | | | | | Cash equivalents: | | | | | | | | Money market funds | $ | 689,129 |
| | $ | — |
| | $ | — |
| | $ | 689,129 |
| Commercial paper | — |
| | 149,940 |
| | — |
| | 149,940 |
| Time deposits | — |
| | 105,397 |
| | — |
| | 105,397 |
| Treasury discount notes | 74,971 |
| | — |
| | — |
| | 74,971 |
| Marketable securities: | | | | | | | | Commercial paper | — |
| | 21,949 |
| | — |
| | 21,949 |
| Treasury discount notes | 9,993 |
| | — |
| | — |
| | 9,993 |
| Corporate debt securities | — |
| | 2,050 |
| | — |
| | 2,050 |
| Total | $ | 774,093 |
| | $ | 279,336 |
| | $ | — |
| | 1,053,429 |
| | | | | | | | | Liabilities: | | | | | | | | Contingent consideration arrangements | $ | — |
| | $ | — |
| | $ | (21,821 | ) | | $ | (21,821 | ) |
| | | | | | | | | | | | | | | | | | December 31, 2016 | | Quoted Market Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total Fair Value Measurements | | (In thousands) | Assets: | | | | | | | | Cash equivalents: | | | | | | | | Money market funds | $ | 667,662 |
| | $ | — |
| | $ | — |
| | $ | 667,662 |
| Commercial paper | — |
| | 123,640 |
| | — |
| | 123,640 |
| Time deposits | — |
| | 79,000 |
| | — |
| | 79,000 |
| Treasury discount notes | 24,991 |
| | — |
| | — |
| | 24,991 |
| Marketable securities: | | | | | | | | Commercial paper | — |
| | 49,797 |
| | — |
| | 49,797 |
| Treasury discount notes | 34,974 |
| | — |
| | — |
| | 34,974 |
| Corporate debt securities | — |
| | 4,571 |
| | — |
| | 4,571 |
| Total | $ | 727,627 |
| | $ | 257,008 |
| | $ | — |
| | $ | 984,635 |
| | | | | | | | | Liabilities: | | | | | | | | Contingent consideration arrangements | $ | — |
| | $ | — |
| | $ | (33,871 | ) | | $ | (33,871 | ) |
|
Schedule of Changes in Assets Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) |
The following tables present the changes in the Company's financial instruments that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3): | | | | | | | | | | | | | | Three Months Ended March 31, | | 2017 | | 2016 | | Contingent Consideration Arrangements | | Auction Rate Security | | Contingent Consideration Arrangements | | (In thousands) | Balance at January 1 | $ | (33,871 | ) | | $ | 4,050 |
| | $ | (33,873 | ) | Total net (losses) gains: | | | | | | Included in earnings: | | | | | | Fair value adjustments | (1,891 | ) | | — |
| | (3,669 | ) | Included in other comprehensive (loss) income | (1,059 | ) | | 5,950 |
| | (1,906 | ) | Fair value at date of acquisition | — |
| | — |
| | (185 | ) | Settlements | 15,000 |
| | — |
| | 312 |
| Proceeds from sale | — |
| | (10,000 | ) | | — |
| Other | — |
| | — |
| | 2,078 |
| Balance at March 31 | $ | (21,821 | ) | | $ | — |
| | $ | (37,243 | ) |
|
Schedule of Changes in Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) |
The following tables present the changes in the Company's financial instruments that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3): | | | | | | | | | | | | | | Three Months Ended March 31, | | 2017 | | 2016 | | Contingent Consideration Arrangements | | Auction Rate Security | | Contingent Consideration Arrangements | | (In thousands) | Balance at January 1 | $ | (33,871 | ) | | $ | 4,050 |
| | $ | (33,873 | ) | Total net (losses) gains: | | | | | | Included in earnings: | | | | | | Fair value adjustments | (1,891 | ) | | — |
| | (3,669 | ) | Included in other comprehensive (loss) income | (1,059 | ) | | 5,950 |
| | (1,906 | ) | Fair value at date of acquisition | — |
| | — |
| | (185 | ) | Settlements | 15,000 |
| | — |
| | 312 |
| Proceeds from sale | — |
| | (10,000 | ) | | — |
| Other | — |
| | — |
| | 2,078 |
| Balance at March 31 | $ | (21,821 | ) | | $ | — |
| | $ | (37,243 | ) |
|
Carrying Value and the Fair Value of Financial Instruments Measured at Fair Value Only for Disclosure Purposes |
The following table presents the carrying value and the fair value of financial instruments measured at fair value only for disclosure purposes: | | | | | | | | | | | | | | | | | | March 31, 2017 | | December 31, 2016 | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value | | (In thousands) | Current portion of long-term debt | $ | (5,000 | ) | | $ | (5,264 | ) | | $ | (20,000 | ) | | $ | (20,311 | ) | Long-term debt, net of current portion | (1,571,982 | ) | | (1,655,064 | ) | | (1,582,484 | ) | | (1,657,861 | ) |
|